Discontinuation report DAKLINZA

Last updated on 2018-09-28 History
Report ID 62566
Drug Identification Number 02444755
Brand name DAKLINZA
Common or Proper name daclatasvir dihydrochloride)
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) Daclatasvir
Strength(s) 60MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 Bottle X 28
ATC code J05AP
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-11-30
Actual discontinuation date
Remaining supply date 2019-11-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Stock will be available until Nov. 30th, 2019
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-09-28 French Compare
v1 2018-09-28 English Compare

Showing 1 to 2 of 2